Literature DB >> 230052

Pseudohypoparathyroidism type II and anticonvulsant rickets.

I Matsuda, Y Takekoshi, M Tanaka, N Matsuura, B Nagai, Y Seino.   

Abstract

A patient treated with anticonvulsants showed hypocalcemia and hyperphosphatemia in association with increased serum parathyroid hormone, reduced serum 25-hydroxy D3, diminished response in phosphorus excretion to exogenous parathyroid hormone and normal response in cyclic AMP excretion. Oral administration of Vitamin D3 resulted in normalization of serum 25-hydroxy D3, calcium, and phosphorus. At this stage, phosphorus excretion after parathyroid hormone returned to normal. These findings suggest that the patient had pseudohypoparathyroidism type II with anti-convulsant medication as a complicating factor.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 230052     DOI： 10.1007/bf00496854

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  10 in total

1.  Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children.

Authors:  K G Tolman; W Jubiz; J J Sannella; J A Madsen; R E Belsey; R S Goldsmith; J W Freston
Journal:  Pediatrics       Date:  1975-07       Impact factor: 7.124

2.  Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclic AMP signal.

Authors:  M Drezner; F A Neelon; H E Lebovitz
Journal:  N Engl J Med       Date:  1973-11-15       Impact factor: 91.245

3.  Pseudohypoparathyroidism type II: restoration of normal renal responsiveness to parathyroid hormone by calcium administration.

Authors:  H J Rodriguez; H Villarreal; S Klahr; E Slatopolsky
Journal:  J Clin Endocrinol Metab       Date:  1974-10       Impact factor: 5.958

4.  Rickets associated with anticonvulsant medication.

Authors:  H L Medlinsky
Journal:  Pediatrics       Date:  1974-01       Impact factor: 7.124

5.  Oculocerebrorenal syndrome in a child with a normal urinary acidification and a defect in bicarbonate reabsorption.

Authors:  I Matsuda; T Takeda; M Sugai; N Matsuura
Journal:  Am J Dis Child       Date:  1969-02

6.  The plasma levels of 25-hydroxyvitamin D in patients with various liver diseases and the response of 25-hydroxyvitamin D to vitamin D treatment.

Authors:  Y Seino; T Shimotsuji; H Kai; C Ikehara; H Yabuuchi
Journal:  Acta Paediatr Scand       Date:  1978-01

7.  Renal tubular acidosis and skeletal demineralization in patients on long-term anticonvulsant therapy.

Authors:  I Matsuda; Y Takekoshi; N Shida; K Fujieda; B Nagai
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

8.  Metabolic acidosis in patients receiving anticonvulsants.

Authors:  B Nagai; I Matsuda; T Kondo; N Taniguchi; S Arashima; T Mitsuyama; Y Oka; M Honma
Journal:  Eur J Pediatr       Date:  1979-11       Impact factor: 3.183

9.  Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism.

Authors:  N H Bell; S Avery; T Sinha; C M Clark; D O Allen; C Johnston
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

10.  Phenobarbital-induced alterations in vitamin D metabolism.

Authors:  T J Hahn; S J Birge; C R Scharp; L V Avioli
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808
  10 in total
  2 in total

1.  Different subtypes of pseudohypoparathyroidism in the same family with an unusual psychiatric presentation of the index case.

Authors:  A J Pollard; M Prendergast; F al-Hammouri; P H Rayner; N J Shaw
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

2.  On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism.

Authors:  K Kruse
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.